EValuation of Systemic Atherothrombosis in Patients With ARTerial Disease of the Lower Limbs — EVART  

Peripheral Arterial Disease Clinical Trial

Official title: EValuation of Systemic Atherothrombosis in Patients With ARTerial Disease of the Lower Limbs

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the prevalence and risk factors, at the time of the diagnosis of PAD, for asymptomatic carotid stenosis and abdominal aortic aneurysm.

Clinical Trial Description

The EVART study is a prospective epidemiological multicenter cohort study, including patients with newly diagnosed PAD (< 1 year). Initial data on medical history, caracterisation of the PAD (risk factors, main sites and severity of the atherosclerotic lesions),clinical evaluation of undetected previous CV events, standardized US duplex examination of the abdominal aorta and carotid arteries and treatment (type and duration) are collected by the physician into an electronic medical record. A phone follow up at 3 months, 1, 2 and 3 years is realised by the Centre for Clinical Research of Grenoble. Data on mortality, revascularization, treatments prescribed (type and duration), cancer onset, cardiovascular events, carotid stenosis, abdominal aortic aneurysm are collected. All these serious adverse events are documented and reviewed by an independent critical events committee. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Abdominal Aortic Aneurysm
• Aortic Aneurysm
• Aortic Aneurysm, Abdominal
• Carotid Stenosis
• Peripheral Arterial Disease
• Peripheral Vascular Diseases

• NCT number: NCT01224600
• Study type: Observational
• Source: Institut de l'Atherothrombose
• Status: Completed
• Phase: N/A
• Start date: January 2008
• Completion date: March 2014